Monocyte distribution width compared with C-reactive protein and procalcitonin for early sepsis detection in the

A la Woo1, Dong Kyu Oh1, Chan-Jeoung Park2

  • 1Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Plos One
|April 15, 2021
PubMed
Abstract

Insights

Monocyte distribution width (MDW) shows diagnostic performance comparable to C-reactive protein (CRP) and procalcitonin (PCT) for sepsis. Combining MDW with quick Sequential Organ Failure Assessment (qSOFA) enhances early sepsis detection.

Area of Science:

  • Clinical diagnostics
  • Biomarker discovery
  • Sepsis research

Background:

  • Monocyte distribution width (MDW) is a potential early sepsis biomarker.
  • Limited comparative studies exist between MDW and conventional sepsis markers like CRP and PCT.

Purpose of the Study:

  • To evaluate MDW as a sepsis biomarker.
  • To compare the diagnostic performance of MDW against CRP and PCT.

Main Methods:

  • Prospective enrollment of 549 adult emergency department patients.
  • Laboratory tests included complete blood count, MDW, CRP, and PCT.
  • Diagnostic performance assessed using ROC curves, sensitivity, and specificity.

Main Results:

  • MDW levels were highest in the sepsis group.
  • MDW demonstrated an AUC of 0.71, comparable to CRP (0.75) and PCT (0.76).
  • MDW achieved 83.0% sensitivity at a cutoff of 19.8.
  • Combining MDW with qSOFA improved AUC to 0.76, outperforming qSOFA alone (0.67).

Conclusions:

  • MDW exhibits diagnostic performance comparable to established sepsis biomarkers.
  • MDW serves as a viable alternative biomarker for sepsis diagnosis.
  • The combination of MDW and qSOFA significantly enhances early sepsis detection capabilities.

Related Concept Videos